NCT01435811View on ClinicalTrials.gov

Dose Range Evaluation of Norovirus Challenge Pool (GII.4, CIN-1)

PHASE1CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

August 31, 2011

Primary Completion Date

April 30, 2012

Study Completion Date

November 30, 2012

Conditions
Norovirus Infections
Interventions
BIOLOGICAL

Norovirus challenge pool (GII.4, CIN-1)

Norovirus challenge pool (GII.4, CIN-1)

Trial Locations (1)

45229

Cincinnati Children's Hospital Medical Center, Cincinnati

Sponsors
All Listed Sponsors
collaborator

LigoCyte Pharmaceuticals, Inc.

INDUSTRY

lead

Children's Hospital Medical Center, Cincinnati

OTHER